These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 28858851

  • 1. Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis.
    Han B, Meng X, Chen H, Chen L, Liu X, Wang H, Liu D, Gao F, Lin L, Ming J, Sun B, Yin S, Wang R, Wu P, Cai J, Jiang C.
    Aging (Albany NY); 2017 Aug 02; 9(8):1885-1897. PubMed ID: 28858851
    [Abstract] [Full Text] [Related]

  • 2. PKM2 promotes glioma progression by mediating CTNNB1 expression.
    Ma C, Feng Y, Zhong K, Wei J.
    Neurol Res; 2024 Jul 02; 46(7):583-592. PubMed ID: 38797679
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
    Xu Q, Dou C, Liu X, Yang L, Ni C, Wang J, Guo Y, Yang W, Tong X, Huang D.
    Biomed Pharmacother; 2018 Nov 02; 107():1692-1704. PubMed ID: 30257387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
    Guo M, Zhao X, Yuan X, Jiang J, Li P.
    Oncotarget; 2017 Apr 25; 8(17):28226-28236. PubMed ID: 28415668
    [Abstract] [Full Text] [Related]

  • 10. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J, Liu G, Wu Y, Ma J, Wu H, Xie Z, Chen S, Yang Y, Wang S, Shen P, Fang Y, Fan S, Shen S, Fang X.
    Mol Cancer; 2019 Oct 29; 18(1):150. PubMed ID: 31665067
    [Abstract] [Full Text] [Related]

  • 11. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G, Wang Y, Lin C, Lai S, Dai H, Wang Z, Dai L, Su H, Song Y, Zhang N, Feng Y, Tang B.
    J Exp Clin Cancer Res; 2021 Sep 22; 40(1):299. PubMed ID: 34551796
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H, Li Z, Yang P, Zhang L, Fan Y, Li Z.
    Cell Signal; 2014 Nov 22; 26(11):2397-405. PubMed ID: 25041845
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q, Guan Y, Li Z, Wang Y, Liu Y, Cui R, Wang Y.
    J Exp Clin Cancer Res; 2019 Aug 16; 38(1):358. PubMed ID: 31419987
    [Abstract] [Full Text] [Related]

  • 17. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
    Chen J, Yu Y, Chen X, He Y, Hu Q, Li H, Han Q, Ren F, Li J, Li C, Bao J, Ren Z, Duan Z, Cui G, Sun R.
    Cell Prolif; 2018 Dec 16; 51(6):e12510. PubMed ID: 30105813
    [Abstract] [Full Text] [Related]

  • 18. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H, Yu L, Liu J, Bian X, Shi C, Sun C, Zhou X, Wen Y, Hua D, Zhao S, Ren L, An T, Luo W, Wang Q, Yu S.
    Oncotarget; 2017 Mar 21; 8(12):19723-19737. PubMed ID: 28160566
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. miR-625-5p/PKM2 negatively regulates melanoma glycolysis state.
    Zhang H, Feng C, Zhang M, Zeng A, Si L, Yu N, Bai M.
    J Cell Biochem; 2019 Mar 21; 120(3):2964-2972. PubMed ID: 30500994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.